Your browser doesn't support javascript.
loading
Research advances in the role and mechanism of peroxisome proliferator-activated receptor alpha in liver diseases / 临床肝胆病杂志
Journal of Clinical Hepatology ; (12): 2351-2354, 2019.
Article Dans Chinois | WPRIM | ID: wpr-778750
ABSTRACT
Peroxisome proliferator-activated receptor alpha (PPARα) is a member of the nuclear receptor superfamily and plays a central regulatory role in lipid metabolism. Recent studies have found that PPARα agonists play a key role in the prevention and treatment of nonalcoholic fatty liver disease, which has also been reported in other liver diseases. This article reviews the role and mechanism of PPARα in nonalcoholic fatty liver disease, alcoholic liver disease, viral hepatitis, cholestatic liver disease, drug-induced liver injury, and hepatocellular carcinoma, so as to provide a reference for the research on the new application of conventional drugs associated with PPARα.

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Journal of Clinical Hepatology Année: 2019 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Journal of Clinical Hepatology Année: 2019 Type: Article